Naples

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis1 trial
• Nephrotic syndrome1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Sanofi2 trials

Running trials

• Recruiting

  A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

  NCT06500702· Phase 2· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Nephrotic syndrome1 recruiting

Closed trials

• Completed

  Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)

  NCT04410978· Phase 3· Sanofi· Source